drugset / Trial / NCT00819884

To Evaluate 24-hr Glucose After OD vs BD AZD1656

NCT00819884

Phase 1 Completed 36 enrolled AstraZeneca
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to compare the 24-hour glucose profiles in diabetic patients treated with metformin following once daily and twice daily oral dosing

Timeline

Start
2009-01
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1656 Small molecule Oral